Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.

Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.

PURPOSE: The diagnosis of localized prostate cancer is difficult due to a lack of cancer-specific biomarkers. Many patients require repeat prostate biopsies to diagnose the disease. We investigated whether aberrant promoter hypermethylation in prostatic fluid could reliably detect prostate cancer....

Full description

Bibliographic Details
Main Authors:	Rouprêt, M, Hupertan, V, Yates, DR, Catto, J, Rehman, I, Meuth, M, Ricci, S, Lacave, R, Cancel-Tassin, G, de la Taille, A, Rozet, F, Cathelineau, X, Vallancien, G, Hamdy, F, Cussenot, O
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Molecular diagnosis of localized prostate cancer by quantitative methylation-specific PCR gene patterns in urine cells obtained by prostate massage
by: Roupret, M, et al.
Published: (2007)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
by: Rouprêt, M, et al.
Published: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
by: Roupret, M, et al.
Published: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
by: Roupret, M, et al.
Published: (2007)

Clinically localised prostate cancer is microsatellite stable.
by: Azzouzi, A, et al.
Published: (2007)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
by: Rehman, I, et al.
Published: (2004)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
by: Roupret, M, et al.
Published: (2007)

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
by: Rouprêt, M, et al.
Published: (2008)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
by: Rehman, I, et al.
Published: (2004)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
by: Rouprêt, M, et al.
Published: (2005)

The Genetic Complexity of Prostate Cancer
by: Eva Compérat, et al.
Published: (2020-11-01)

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
by: Rehman, I, et al.
Published: (2004)

Molecular Anatomy of Prostate Cancer and Its Implications in Active Surveillance and Early Intervention Strategies
by: Sandy Figiel, et al.
Published: (2023-10-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
by: Roupret, M, et al.
Published: (2004)

Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies)
by: Geraldine Cancel-Tassin, et al.
Published: (2015-02-01)

Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly: a feasibility study with 10 years follow-up
by: Amine B. El Fegoun, et al.
Published: (2011-04-01)

Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.
by: Cussenot, O, et al.
Published: (2007)

Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma.
by: Rouprêt, M, et al.
Published: (2007)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
by: Rehman, I, et al.
Published: (2003)

Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A.
by: Leiblich, A, et al.
Published: (2007)

Re: Initial complete laparoendoscopic single-site surgery robotic assisted radical prostatectomy(LESS-RARP)
by: Eric Barret, et al.
Published: (2009-02-01)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
by: Leiblich, A, et al.
Published: (2006)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer
by: Catto, J, et al.
Published: (2006)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
by: Catto, J, et al.
Published: (2006)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
by: Yates, DR, et al.
Published: (2005)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
by: Yates, DR, et al.
Published: (2006)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
by: Yates, DR, et al.
Published: (2006)

The Calcium-Sensing Receptor is A Marker and Potential Driver of Neuroendocrine Differentiation in Prostate Cancer
by: Fanny Bery, et al.
Published: (2020-04-01)

Focal brachytherapy for localized prostate cancer: Mid-term outcomes
by: I. Nunes-Silva, et al.
Published: (2020-07-01)

Prostate cancer proteomics: The urgent need for clinically validated biomarkers
by: Evans, C, et al.
Published: (2009)

A comparative analysis of the behaviour of urothelial carcinoma with respect to anatomical location
by: Catto, J, et al.
Published: (2007)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
by: van Oers, J, et al.
Published: (2009)

MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers
by: Andrea Padoan, et al.
Published: (2018-07-01)

Evaluation of the efficacy of post prostatic massage urine cytology in diagnosis of various prostatic lesions with cytohistological and clinical correlation
by: Monisha Choudhury, et al.
Published: (2017-01-01)

DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer.
by: Rehman, I, et al.
Published: (2007)

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
by: Rehman, I, et al.
Published: (2004)

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
by: Calvert, N, et al.
Published: (2003)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
by: Hamdy, F
Published: (2005)

Changes in circulating microRNA levels associated with prostate cancer.
by: Bryant, R, et al.
Published: (2012)

Circulating microRNAs are associated with the development and progression of prostate cancer
by: Bryant, R, et al.
Published: (2012)